Yi Ma
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Receptor Mechanisms and Signaling 4
- RNA Interference and Gene Delivery 3
- Advanced biosensing and bioanalysis techniques 3
- Oncology 12
- Peptidase Inhibition and Analysis 5
- Co-authors
- Yueqing Gu (14 shared papers)Zhaohui Wang (6 shared papers)Weidong Gao (4 shared papers)Min Zhang (4 shared papers)Zhihao Han (9 shared papers)Siwen Li (2 shared papers)Jiaqi Zhang (1 shared paper)Yuxi Liu (1 shared paper)
- Journals
- Biomaterials Science (3 papers)International Journal of Nanomedicine (3 papers)Theranostics (2 papers)Evidence-based Complementary and Alternative Medicine (2 papers)Advanced Functional Materials (2 papers)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Yi Ma
44 papers receiving 845 citations
Peers
Comparison fields: 5 of 106
- Cancer Research 137
- Biomaterials 117
- Biomedical Engineering 315
- Molecular Biology 370
- Toxicology 13
Countries citing papers authored by Yi Ma
This map shows the geographic impact of Yi Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Ma more than expected).
Fields of papers citing papers by Yi Ma
This network shows the impact of papers produced by Yi Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Ma. The network helps show where Yi Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Yi Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 156 | |
| 2 | 2016 | 91 | |
| 3 | 2017 | 84 | |
| 4 | 2017 | 49 | |
| 5 | 2018 | 45 | |
| 6 | 2014 | 38 | |
| 7 | 2017 | 33 | |
| 8 | 2019 | 31 | |
| 9 | 2017 | 30 | |
| 10 | 2022 | 28 | |
| 11 | 2023 | 23 | |
| 12 | 2017 | 22 | |
| 13 | 2020 | 22 | |
| 14 | 2020 | 21 | |
| 15 | 2019 | 17 | |
| 16 | 2020 | 17 | |
| 17 | 2021 | 14 | |
| 18 | 2019 | 13 | |
| 19 | 2020 | 11 | |
| 20 | 2023 | 11 |
About Yi Ma
Yi Ma is a scholar working on Molecular Biology, Oncology, Immunology, Cellular and Molecular Neuroscience and Biomedical Engineering, having authored 44 papers that have together received 858 indexed citations. Recurring topics across this work include Neuropeptides and Animal Physiology (10 papers), Immunotherapy and Immune Responses (8 papers), Nanoplatforms for cancer theranostics (5 papers), Peptidase Inhibition and Analysis (5 papers), Receptor Mechanisms and Signaling (4 papers), RNA Interference and Gene Delivery (3 papers), Advanced biosensing and bioanalysis techniques (3 papers) and Cell Adhesion Molecules Research (2 papers). The work is most often cited by research in Cancer Research (137 citations), Biomaterials (117 citations), Biomedical Engineering (315 citations), Molecular Biology (370 citations) and Toxicology (13 citations). Yi Ma has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Yueqing Gu, Zhaohui Wang, Weidong Gao, Min Zhang, Zhihao Han, Siwen Li, Jiaqi Zhang, Yuxi Liu, An Hong and Guijuan Zhang. Their work appears in journals such as Biomaterials Science, International Journal of Nanomedicine, Theranostics, Evidence-based Complementary and Alternative Medicine and Advanced Functional Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.